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1 Both authors have contributed equally.S100A8/A9 promotes NADPH oxidase in HaCaT keratinocytes and subsequently increases NFjB acti-
vation, which plays important roles in the balance between epidermal growth and differentiation.
S100A8/A9-positive HaCaT cells present with a signiﬁcantly reduced rate of cell division and greater
expression of two keratinocyte differentiation markers, involucrin and ﬁlaggrin, than control cells.
S100A8/A9 mutants fail to enhance NFjB activation, TNFa-induced IL-8 gene expression and NFjB
p65 phosphorylation, and S100A8/A9-positive cells demonstrate better cell survival in forced sus-
pension culture than mutant cells. S100A8/A9 is induced in epithelial cells in response to stress.
Therefore, S100A8/A9-mediated growth arrest could have implications for tissue remodeling and
repair.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction expressing a constitutively nuclear form of the NFjB subunit p50The epidermis is a stratiﬁed squamous epithelium that under-
goes continuous self-renewal to maintain its protective function.
In the course of homeostasis, dividing cells in the basal layer con-
tinually execute a program of terminal differentiation, move out-
wards and are sloughed from the skin surface [1]. Growth factors
modulate overall skin homeostasis but the intracellular signaling
pathways responsible for controlling the balance between prolifer-
ation and differentiation in keratinocytes are largely unknown.
A number of gain or loss of function studies in mice have
demonstrated that NFjB and components of this system including
IKK-a are important for balancing growth and differentiation in the
epidermis [2]. Growth of the epidermis is inhibited in mice over-chemical Societies. Published by E
arboxy-ﬂuorescein diacetate
sorting; ROS, reactive oxygen
/ IMCI, Helmholtz Centre for
eig, Germany, Tel.: +49 531
oc@uni-muenster.de (C. Ker-in skin cells [3]. Knocking out IKKa results in a severe cutaneous
phenotype characterized by incomplete epidermal differentiation
[4] and mice with an epidermis-speciﬁc deletion of IKK-b develop
a severe inﬂammatory skin disease caused by a TNFa-mediated, ab
T cell-independent inﬂammatory response that develops shortly
after birth [5]. Conversely, over-expression of IjB results in hyper-
plasia and inﬂammation, and leads to squamous cell carcinomas
[6].
The NFjB family includes the p65, p50 and c/rel proteins, which
can homodimerize and heterodimerize among themselves [7].
These proteins are stored latently in the cytoplasm bound to the
inhibitory protein IjB. A number of stimuli including TNFa activate
IKKs, kinases that phosphorylate IjB and induce its degradation.
The degradation of IjB results in activation and nuclear transloca-
tion of NFjB. However, redox mechanisms also play a role in NFjB
activation [8]. Recently, we demonstrated that increased levels of
reactive oxygen species (ROS) caused by the interaction of the
S100 proteins, S100A8 and S100A9, with epithelial NADPH oxi-
dases resulted in increased NFjB activation followed by increased
IL-8 gene expression [9]. This study is consistent with the view that
NFjB is a redox-sensitive transcription factor.
S100A8 and S100A9 belong to the multigenic S100 protein fam-
ily, which consists of non-ubiquitous cytoplasmic Ca2+-bindinglsevier B.V. All rights reserved.
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pressed in myeloid cells [11]. In phagocytes, S100A8 and S100A9
form heteromeric complexes that bind polyunsaturated fatty acids
such as arachidonic acid (AA) in a calcium-dependent manner [12].
S100A8/A9 participates in phagocyte NADPH oxidase activation by
transferring AA to membrane-bound Nox2 (gp91phox) [13]. AA is an
essential factor for NADPH oxidase as it binds to gp91phox, which
induces structural changes in cytochrome b558.
Normal S100A8 and S100A9 are expressed at minimal levels in
the epidermis. However, their expression is transiently induced in
keratinocytes after epidermal injury [14,15] and UVB irradiation
[16], and the proteins are expressed at extremely high levels in
psoriatic keratinocytes [17]. Furthermore, their expression is in-
duced by pro-inﬂammatory cytokines such as TNFa and IL1b. Re-
cently, we presented evidence that a complex of Poly (ADP-
ribose) polymerase (PARP-1) and Ku70/80 drives stress response-
speciﬁc S100 gene expression [18].
The stress response-induced expression of the S100 proteins
points to an important role in skin pathology. Therefore, the pres-
ent study was undertaken to investigate the cellular consequences
of S100A8/A9 over-expression in epithelial cells. S100A8/A9-
over-expressing HaCaT keratinocytes were analyzed with respect
to cellular responses including proliferation, cell survival and
differentiation.2. Material and methods
2.1. Plasmids
Construction of pVIVO-S100A8/A9 (H103,104,105K106A), pVI-
VO-S100A8/A9 (T113A), pVIVO-S100A8/A9 and pVITRO-S100A8/
A9 was performed as previously described [9]. All constructs were
tested by sequencing.
2.2. Cell culture
HaCaT (human keratinocyte cell line) cells were cultured in Dul-
becco’s modiﬁed Eagle’s medium (Biochrom AG, Germany) con-
taining 10% heat-inactivated fetal bovine serum (Biowest,
France), 100 units of penicillin (Biochrom AG) and 2 mM L-gluta-
mine (Biochrom AG) at 37 C in a humidiﬁed atmosphere contain-
ing 5% CO2. MCF-7 (human breast adenocarcinoma cell line) cells
were cultured in 90% RPMI 1640 containing 10% heat-inactivated
fetal bovine serum, MEM non-essential amino acids, 1 mM sodium
pyruvate and 10 lg/ml human insulin at 37 C in a humidiﬁed
atmosphere containing 5% CO2. The Ethical Committee of the Uni-
versity Hospital, Muenster, Germany, approved all the studies de-
scribed. The research was conducted according to the Declaration
of Helsinki Principles.
2.3. Transient expression of S100A8 and S100A9
Transient transfection of HaCaT cells was performed as previ-
ously described [9]. Cell viability was determined 12 h post-trans-
fection using the trypan blue exclusion assay. S100A8 and S100A9
expression was conﬁrmed by western blotting using antibodies di-
rected against each protein.
2.4. Luciferase activity assays
NFjB luciferase reporter assays were performed as previously
described [9]. Luminescence was determined using a Centro LB
960 luminometer and experiments were performed in triplicate.
The luminescence of non-stimulated cells was subtracted from
that of TNFa-stimulated cells, and the data were normalizedrelative to b-galactosidase activity. The data are presented as
mean ± S.E.M.
2.5. Fluorescence-activated cell sorting (FACS) staining
HaCaT cells were labeled with carboxy-ﬂuorescein diacetate
succinimidyl ester (CFDA, C-1157, Molecular Probes). After 24 h,
CFDA-labeled cells were transfected with pVITRO-S100A8/A9. For
transfection, 2  106 CFDA-labeled HaCaT cells were seeded on to
a 10 cm plate. Prior to the addition to cells, polyethylenimine
(PEI, 408727, Sigma–Aldrich) was mixed with 36 lg DNA in Opti-
Mem (without FBS) and incubated for 30 min at room temperature.
After cultivation for various time intervals, cells were ﬁxed using
BD Phosﬂow Fix Buffer I and Perm Buffer III as recommended by
the manufacturer.
For FACS analysis, cells were stained at 4 C for 30 min with
1 lg of S100A9-speciﬁc rabbit polyclonal antibody and 1 lg of
various mouse monoclonal antibodies including anti-ﬁlaggrin
(Dianova, #DLN 09496), anti-involucrin (Dianova, #DLN 07099)
and Alexa Fluor 647–conjugated mouse anti-pS529-NFjB p65
(BD, #558422). The cells were washed with wash/staining solu-
tion, and 1 lg of secondary Cy3-conjugated goat anti-rabbit anti-
body (Jackson Immuno Research, #111-166-003) was added with
1 lg Alexa 647-conjugated goat anti-mouse antibody (Invitrogen,
#A21236); for some experiments, directly-conjugated antibodies
were used after incubation at 4 C for 30 min. Cells were washed
twice, resuspended in 500 ll wash/staining solution, and analyzed
using a FACS Calibur ﬂow cytometer equipped with CellQuestPro
software (BD PharMingen). There was no non-speciﬁc ﬂuores-
cence between Alexa 647 and Cy3 staining. Each analysis included
at least 10000 events. Quadrants were set according to negative
control staining with mouse IgG1 as an isotype control for mono-
clonal antibody and rabbit IgG as an isotype for the polyclonal
antibody, respectively. Values within dot plots indicate the per-
centage of cells in the respective quadrants. The relative antigen
expression indicated was calculated as the percentage of anti-
gen-expressing cells in either S100A9-positive or negative cell
subgroups.
2.6. Quantitative PCR
Total RNA was extracted using an RNA Isolation Kit (Qiagen,
Germany) and ﬁrst strand cDNA was synthesized according to
common molecular biological techniques. The mRNA levels of












The CT values of genes of interest were normalized to GAPDH.
IL-8 gene expression is given in relation to the corresponding IL-
8 gene expression in non-stimulated cells: DCT IL-8 (TNFa  DCT
IL-8 (non-stimulated) = DDCT IL-8 (TNFa).
2.7. Anchorage-independent survival assay
HaCaT cells were transfected with empty pVITRO or pVITRO-
S100A8/A9wt expression plasmids. After 24 h (or extended incuba-
tion intervals) the cells were trypsinized, resuspended in 2 ml
medium and added to plates pre-coated with 0.9% agarose
(104cells per well), with or without TNFa (10–50 ng/ml) and NFjB
inhibitor III (10 lmol/l) for 24 h. Aliquots of cells were reseeded in
fresh medium on tissue culture-treated plastic. Crystal violet
(0.005%) staining of re-attached viable cells was carried out 24 h
Fig. 1. CFDA assay of pVITRO-S100A8/A9-transfected HaCaT cells. HaCaT keratino-
cytes were labeled with CFDA and transfected with pVITRO-S100A8/A9. FACS
analysis was performed as described in Section 2.5. No background was detectable
when isotype and secondary antibodies were tested during control staining (see
Fig. S1, right histograms, shaded gray graph). (A and B) Dot plot of CFDA versus
S100A9 antigen expression for day three (A) and day 13 (B) cultured S100A8/A9-
HaCaT keratinocytes. Inset: Numbers within plots denote percentage of cells in the
respective quadrants. (C and D) Histograms of S100A9-negative (C) and S100A9-
positive cells (D) are shown. Cells were gated on S100A9+ or S100A9 upon staining
in (A) and (B). day 3 = gray curve, day 13 = open curve.
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tiﬁed by the absorbance at 560 nm.
2.8. Stable transfection of MCF-7 cells with S100A8 and S100A9
For stable transfection, MCF-7 cells were seeded in 6-well plates
24 h prior to transfection (2.5  105 cells/well). Two micrograms of
pVITRO-S100A/8A9 plasmid DNAwere mixed with 9 ll of Lipofect-
amine transfection reagent and transfected into the cells according
to the manufacturer’s instructions. Empty pVITRO vector was
transfected as a control. Twenty-four hours after transfection, the
cells were trypsinized, diluted, and placed in 96-well plates. Trans-
fected cells were selected with 500 lg/ml hygromycin. Individual
hygromycin-resistant clones were screened for S100A8 and
S100A9 using western blotting. Ten S100A8/A9-positive clones
were pooled for further characterization. Morphological changes
were observed and photographed with a phase-contrast
microscope.
2.9. SDS–PAGE and western blot analysis
SDS–PAGE and western blotting were performed according to
standard procedures and developed using the ECL PlusTM western
blotting detection reagents from Amersham Biosciences.
2.10. BrdU immunohistochemistry proliferation assay
The bromodeoxyuridine (BrdU) immunohistochemistry prolif-
eration assay kit was purchased from Calbiochem Inc. (San Diego,
CA). For BrdU assays, MCF7wt and MCF-7/a8a9 (107) cells were
starved for 48 h with medium containing 0.2% FCS followed by
the addition of medium containing 10% FCS. After 24 h, 1 lM BrdU
was added for 16 h and the BrdU immunohistochemistry prolifer-
ation assay was conducted according to the manufacturer’s
instructions.
2.11. Data analysis
Data are presented as mean ± S.E.M. Statistical signiﬁcance be-
tween means was established using a Student’s t-test, and proba-
bility values of P < 0.05 were considered to represent signiﬁcant
differences.3. Results and discussion
3.1. S100A8/A9-overexpression leads to reduced proliferation in HaCaT
keratinocytes
Among the pathways with important roles in the regulation of
keratinocyte growth and differentiation is the NFjB pathway.
NFjB activation has been demonstrated to induce growth arrest
in epithelial cells opposite immune cells [3] and recently our group
demonstrated that S100A8/A9 promotes epithelial NADPH oxi-
dase(s) and subsequent increases NFjB activation [9]. Therefore,
the effect of S100A8/A9 over-expression on cell proliferation was
investigated by analyzing the rate of cell division using the CFDA
labeling technique. HaCaT keratinocytes were labeled with CFDA
and transfected with pVITRO-S100A8/A9. Cells were cultured for
three and 13 days, and cell division/proliferation was monitored
using FACS. To discriminate between S100A8/A9-expressing and
non-expressing cells, intracellular S100A9 was stained using a
S100A9-speciﬁc polyclonal antibody.
Proliferation of S100A9-positive and S100A9-negative cells after
three and 13 days is presented in Fig. 1. Dot plots demonstrating
CFDA ﬂuorescence versus S100A9 antigen expression in HaCaTkeratinocytes cultured for three (Fig. 1A) and 13 days (Fig. 1B)
show the characteristic decline in CFDA ﬂuorescence in S100A9-
negative cells indicative of cell division; the degree of shift in
S100A9-positive HaCaT keratinocytes was signiﬁcantly less pro-
nounced by day 13.
Representative proliferation of S100A9-negative HaCaT kerati-
nocytes demonstrated a fairly uniform bell-shaped distribution of
ﬂuorescence staining at day three (Fig. 1C, gray curve). By day 13
(open curve), the mean ﬂuorescence was strongly shifted to the
left, indicative of cell division. However, the degree of the shift
was lower in S100A9-HaCaT keratinocytes than in S100A9-nega-
tive cells (Fig. 1D). The delay in the leftward shift associated with
proliferation was evident as early as day three (gray curve) and
was pronounced by day 13 (open curve). Therefore, S100A8/A9-
expressing HaCaT keratinocytes continued to divide, albeit at a sig-
niﬁcantly slower rate than S100A8/A9-negative cells. More de-
tailed analysis is presented in Fig. 1S.
3.2. S100A8/A9 expression interferes with NFjB activation
To conﬁrm the anti-proliferative effect of S100A8/A9-mediated
NFjB activation, whether S100A8/A9 expression affected NFjB
p65 phosphorylation was investigated. HaCaT keratinocytes were
transfected with pVITRO-S100A8/A9 and cultured for two and six
days. For FACS analysis, cells were double-stained with K10-
895.12.50 monoclonal antibody, which recognizes the phosphory-
lated serine 529 in the transactivation domain of the human NFjB
p65 subunit, and S100A9-speciﬁc polyclonal antibody (Fig. 2A–C).
Isotype and secondary antibodies revealed no background staining
(data not shown).
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phosphorylation detected using FACS in S100A9-positive HaCaT
keratinocytes compared with results for S100A9-negative cells.
The increase in NFjB p65 phosphorylation was evident as early
as day two but was not statistically signiﬁcant (Figs. 2A and C).
However, by day six the pronounced increase in NFjB p65 phos-
phorylation was signiﬁcant (P-value < 0.05; n = 5; Figs. 2B and C).
Importantly, this effect did not rely on the release of S100A8/A9
and its binding to cell surface receptors. This was conﬁrmed byFig. 2. S100A8/A9 expression interferes with NFjB activation. (A–C) To investigate w
transfected with pVITRO-S100A8/A9 and cultured for various time intervals. For FACS an
details are described in Section 2.5. (A and B): FACS analysis of two day (A) and six day
percentage of cells in the respective quadrants, and data are representative of ﬁve ind
mean ± S.E.M. Statistical signiﬁcance of differences between means was established by
panel) and S100A8/A9wt-transfected HaCaT keratinocytes (right panel). HaCaT cells we
S100A8/A9wt expression plasmid, as described in Section 2.4, and luciferase activity wa
activity was determined for three independent transfection reactions. Inset: Transfection
Effect of S100A8/A9wt and mutants on NFjB activation. HaCaT cells were co-transfecte
S100A8/A9 expression vectors as indicated. After 48 h the cells were treated with 5
transfection reactions. Luminescence of unstimulated cells was subtracted from that o
activities. Asterisks indicate statistically signiﬁcant differences in S100A8/A9wt- and m
gene expression. HaCaT cells were transfected with various S100A8/A9 expression vectors
gene expression analysis was performed as described in Section 2.6. CT values of IL
corresponding IL-8 gene expression in non-stimulated cells: DCT IL-8 (TNFa)  DCT IL-8 (
independent transfection reactions. Asterisks indicate statistically signiﬁcant differences i
culture due to enhanced NFjB activation. HaCaT cells were suspended in plates pre-coate
(10 lmol/;) for 24 h. Aliquots of cells were reseeded in fresh medium on tissue culture–t
later. Asterisks indicate statistically signiﬁcant differences in the S100A8/A9wt- and muimmunoprecipitation using the S100A8/A9-speciﬁc monoclonal
antibody, 27E10 (data not shown). Furthermore, HaCaT cells were
transfected with NFjB luciferase reporter plasmids and stimulated
with various concentrations of exogenous S100A8/A9. However, no
increase of luciferase activity was detected (data not shown).
Complementation of HaCaT cells with S100A8/A9 results in a
signiﬁcant increase in NADPH oxidase activity and enhanced NFjB
activation [9] in accordance with NFjB being a redox-sensitive
transcription factor [8]. For further conﬁrmation, the promotinghether S100 expression affects NFjB phosphorylation, HaCaT keratinocytes were
alysis, cells were incubated with Abs against S100A9 and pS529-NFjB p65. Further
(B) cultured S100A8/A9-HaCaT keratinocytes. Inset: Numbers within plots denote
ependent experiments with similar expression patterns. (C) Data are presented as
a Student’s t-test. 2 d: ; 6 d:j. (D) NFjB luciferase reporter assay in mock- (left
re co-transfected with NFjB luciferase reporter plasmid, empty pVIVO or pVIVO-
s measured after stimulation with various TNFa concentrations for 3 h. Luciferase
efﬁciency was determined by b-galactosidase activity using an enzyme assay kit. (E)
d with various combinations of NFjB -regulated luciferase reporter constructs and
0 ng/ml TNFa for 4 h. Luciferase activity was determined for three independent
f TNFa-stimulated cells, and the data were normalized relative to b-galactosidase
utant-transfected cells. (F) Effect of S100A8/A9 and mutants on TNFa-induced IL-8
as indicated. After 24 h the cells were treated with 50 ng/ml TNFa for 18 h, and IL-8
-8 were normalized to GAPDH. IL-8 gene expression is given in relation to the
non-stimulated) = DDCT IL-8 (TNFa). IL-8 gene expression was determined for three
n S100A8/A9wt- and mutant-transfected cells. (G) Cell survival in forced suspension
d with 0.9% agarose and with or without TNFa (10 ng/ml) and the NFjB inhibitor III
reated plastic. Crystal violet staining of re-attached viable cells was carried out 24 h
tant-transfected cells.
444 A. Voss et al. / FEBS Letters 585 (2011) 440–446effect of S100A8/A9 on NFjB activation was analyzed using a NFjB
reporter assay. HaCaT keratinocytes were transfected with pVI-
TRO-S100A8/A9 and stimulated with increasing concentrations of
TNFa for 3 h (Fig. 2D). b-Galactosidase activity measurements
demonstrated that the cells were transfected with comparable efﬁ-
ciency (Fig. 2D inset). The luciferase assay revealed that TNFa-in-
duced reporter expression of NFjB was signiﬁcantly higher in
HaCaT cells after complementation with S100A8/A9wt (Fig. 2D
right panel, black bars) than in mock-transfected cells (Fig. 2D left
panel, gray bars). Luciferase activity in mock- and S100A8/A9wt-
transfected cells increased with increasing concentrations of TNFa.
Optimal NFjB activation was achieved at 50 ng/ml TNFa.
Two distinct features of S100A8/A9 are involved in promoting
NADPH oxidase activity: (1) the unique C-tail of S100A9 containing
a motif comprising four consecutive basic amino acid residues
(His103-His105, Lys106) to which the fatty acid carboxyl-group
of AA, an essential cofactor for NADPH oxidase activation, is bound
[12,13]; (2) the Thr113 residue of S100A9 that is phosphorylated
upon cellular activation [11]. Therefore, HaCaT keratinocytes were
co-transfected with NFjB luciferase reporter plasmid and expres-
sion plasmids for S100A8/A9 wild-type (pVIVO-S100A8/A9wt)
and the two S100A8/A9 mutants (pVIVO-S100A8/A9-T113A or pVI-
VO-S100A8/A9-H103-105K106A) followed by stimulation with
50 ng/ml TNFa for 4 h (Fig. 2E). Co-transfection with b-galactosi-
dase-expressing plasmid was used as an internal control to verify
efﬁciency of transfection.
Western blotting demonstrated similar expression of S100A9wt
and mutants in transfected HaCaT cells (data not shown). The b-
galactosidase activity measurements demonstrated that the trans-
fection efﬁciencies were comparable (data not shown). The lucifer-
ase reporter assay revealed that TNFa-induced reporter expressionFig. 3. S100A8/A9 over-expression affects cellular differentiation. HaCaT keratinocytes w
and E) days. For FACS analysis, cells were incubated with Abs against S100A9, involuc
revealed no background staining (data not shown). Inset: Numbers within plots denote p
independent experiments with similar expression patterns. (C and F): Data are prese
established using a Student’s t-test. 2 d: ; 6 d:j.was signiﬁcantly higher in S100A8/A9wt-overexpressing HaCaT
cells than in S100A8/A9 mutant-transfected cells (P < 0.05)
(Fig. 2E). Minimal reporter expression was observed if either
S100A8/A9 mutant or S100A8/A9 wild type-over expressing HaCaT
cells were co-transfected with the negative control plasmid (data
not shown). TNFa-induced reporter expression was completely
inhibited by the NFjB inhibitor III (data not shown). The data indi-
cate that S100A8/A9-enhanced NADPH oxidase affects down-
stream signaling including NFjB activation.
IL-8 is expressed at very low levels in resting cells but its pro-
duction is rapidly induced by pro-inﬂammatory cytokines, bacte-
rial or viral products and cellular stress, via NFjB activation [9].
Therefore, TNFa-induced IL-8 expression in S100A8/A9wt-over-
expressing and S100A8/A9 mutant-transfected cells was investi-
gated using real-time PCR.
As demonstrated in Fig. 2F, IL-8 gene expression is increased
n(6.5–4.0) = 5.7 and n(6.5–3.2) = 9.8-fold in S100A8/A9wt-over-
expressing HaCaT keratinocytes compared with S100A8/A9
(T113A) or S100A8/A9 (H103-105K106A)-transfected cells, respec-
tively. These data indicate the involvement of both S100 phosphor-
ylation and AA-binding in TNFa-induced NFjB activation of HaCaT
keratinocytes.
NFjB activity enhances HaCaT cell survival in forced suspension
culture [19]. Therefore, mock- and pVITRO-S100A8/A9-transfected
HaCaT keratinocytes were compared in the anchorage-indepen-
dent survival assay (Fig. 2G). Consistent with the previous ﬁnding,
TNFa-treated HaCaT cells presented with enhanced cell survival in
forced suspension culture that was abrogated in the presence of
NFjB inhibitor III, indicating that cell survival was accomplished
by up-regulating NFjB activity. Signiﬁcantly more S100A8/A9-
over-expressing HaCaT cells survived in the absence of TNFa thanere transfected with pVITRO-S100A8/A9 and cultured for two (A and D) and six (B
rin (A–C) or ﬁlaggrin (D–F). The corresponding isotype and secondary antibodies
ercentage of cells in the respective quadrants, and data are representative of seven
nted as mean ± S.E.M. Statistical signiﬁcance of differences between means was
A. Voss et al. / FEBS Letters 585 (2011) 440–446 445in mock-transfected cells. This is consistent with the results ob-
tained using NFjB reporter assays and FACS analysis using the
anti-phospho p65-NFjB (K10-895.12.50) monoclonal antibody.
3.3. S100A8/A9-overexpression triggers expression of involucrin and
ﬁlaggrin
Studies on mice have demonstrated an important role for NFjB
in keratinocyte proliferation, differentiation and growth arrest
(senescence). NFjB is present in all epidermal layers but is present
only in the cell nucleus in suprabasal layers, further implicating
NFjB in epidermal differentiation [3]. Filaggrin is one of the key
proteins that facilitate terminal differentiation of the epidermis
and formation of the skin barrier; keratinocytes process proﬁlag-
grin into ﬁlaggrin and undergo speciﬁc changes that mark terminal
differentiation [20]. Therefore, the expression of two keratinocyte
differentiation markers, involucrin and ﬁlaggrin, was investigated
in S100A8/A9 over-expressing cells (Figs. 3A–F).
After two days’ cultivation, 90.0 ± 7.4% of S100A9-expressing
cells were positive for involucrin expression whereas 80.8 ± 9.0%
S100A9-negative cells expressed involucrin (P-value < 0.05). After
six days cultivation, 96.3 ± 2.7% of S100A9-postive HaCaT keratino-
cytes and 88.2 ± 8.6% of S100A9-negative cells expressed involu-
crin (P-value < 0.05) (Figs. 3A and B).
Approximately 32.8 ± 21.2% of S100A9-positive cells expressed
ﬁlaggrin after two days (P-value < 0.05) and 52.8 ± 13.8% expressed
this protein after six days. In contrast, only 8.7 ± 4.8% of S100A9-
negative cells expressed ﬁlaggrin after two days and 24.6 ± 10.0%
after six days (P-value < 0.05) (Figs. 3D and E). These data indicate
that S100A9-positive cells probably undergo abnormal early or late
phase differentiation. FACS analysis revealed deregulation of early
and late differentiation markers.Fig. 4. S100A8/A8 expression leads to reduced proliferation of MCF-7/a8a9 cells. (A) We
S100A8 and S100A9 were detected by western blotting using the corresponding antibod
majority of MCF-7/a8a9 cells displayed reduced cell adherence, with some round cells p
followed by further cultivation for 12 days. FACS analysis was performed as described in
from one representative experiment, of three experiments performed, are presented. Day
cells (107) were starved for 48 h with medium containing 0.2% FCS followed by the additio
BrdU immunohistochemistry proliferation assay was conducted according to the manuf3.4. MCF-7 cells stably over expressing S100A8/A9 display reduced
proliferation rate
To investigate whether S100A8/A9 over-expression caused
growth arrest in other cells, several breast tumor cells were ana-
lyzed with regard to S100 gene expression [21]. S100A8 and
S100A9 were present at extremely low levels in MCF-7 cells; there-
fore, these cells were chosen for transfection with pVITRO-S100A8/
A9 plasmid. After hygromycin selection, MCF-7 cell lines express-
ing S100A8 and S100A9 (MCF-7/a8a9) were obtained. Western
blotting revealed the expression of proteins with molecular
weights of approximately 10,000 and 14,000 Da in MCF 7/a8a9
cells, while MCF-7wt cells did not express these proteins (Fig. 4A).
The morphology and growth pattern of stable MCF-7/a8a9 cells
differed markedly fromMCF-7wt controls. MCF-7/a8a9 cells multi-
plied more slowly than the wild type controls and never reached
conﬂuence during the time periods utilized in this study. The
majority of the cells displayed reduced cell adherence, with
rounded cells present in suspension (Fig. 4B).
The CFDA dilution assay conﬁrmed that S100A8/A9 over-
expression reduced proliferation (Fig. 4C and D). Representative
proliferation of MCF-7wt cells demonstrated a shift in the mean
ﬂuorescence to the left, indicative of cell division (Fig. 4C). How-
ever, the mean ﬂuorescence of MCF 7/a8a9 cells demonstrated a
delay in the leftward shift associated with proliferation (Fig. 4D).
These data were conﬁrmed using BrdU cell proliferation assays
(Fig. 4E), indicating that MCF7-a8a9 cells proliferate more slowly
than wild type cells.
In conclusion, the present study demonstrates for the ﬁrst time
that S100A8/A9-over expression affects the proliferation and
differentiation of HaCaT keratinocytes. In view of the stress re-
sponse-induced transient expression of S100A8/A9, it is concludedstern blot of MCF-7wt and MCF-7/a8a9 cell lysates (50 lg) subjected to SDS–PAGE.
ies. (B) Morphology of MCF-7wt (left panel) and MCF-7/a8a9 cells (right panel). The
resent in suspension. (C and D): CFDA dilution assay. Cells were labeled with CFDA
Section 2.5. Histograms of MCF-7wt (C) and MCF-7/a8a9 cells (D) are shown. Data
2 = gray curve, day 12 = open curve. (E) For BrdU assays, MCF-7wt and MCF-7/a8a9
n of medium containing 10% FCS. After 24 h, 1 lM BrdU was added for 16 h, and the
acturer’s instructions.
446 A. Voss et al. / FEBS Letters 585 (2011) 440–446that S100A8/A9-mediated growth arrest could be important in reg-
ulating cellular processes such as wound healing and the preven-
tion of UV-induced skin carcinogenesis. S100A8/A9-mediated
growth arrest is required for cell fate decisions, i.e. whether a sur-
vival phase is followed by differentiation, proliferation or apopto-
sis. Recently, Nukui et al. [22] reported that S100A8/A9
stimulates proliferation of normal human keratinocytes and this
study demonstrates that intracellular S100A8/A9 functions as a
mediator for growth suppression. The study of Nukui et al. [22]
provides evidence that S100A8/A9 enhances growth of normal hu-
man keratinocytes when acting on the cells exogenously. There-
fore, S100A8/A9 plays an ambivalent role with respect to growth
regulation of keratinocytes. Further studies are required to eluci-
date its role in skin biology.
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